The Food and Drug Administration (FDA) has allowed the direct-to-consumer genetics company 23andMe to offer a test for mutations in the BRCA1 and BRCA2 genes, the agency announced today (March 6). The three mutations included in the screen increase the risk of breast and ovarian cancer, and are most common among people of Ashkenazi Jewish decent.
New research from The University of Texas at Dallas supports the growing consensus that pain begins differently for men and women at the cellular level. Ted Price BS’97, Salim Megat and their colleagues in the Pain Neurobiology Research Group recently found that a specific manipulation of receptors in the nervous system for the neurotransmitter dopamine impairs chronic pain in male mice, but has no effect on females.
Diabetes is a more diverse disease than medicine currently acknowledges – and treatments could be improved by splitting the disease into more types, according to a new study. The two “types” of the disease are not precise enough – and the adult-onset varieties of the disease should be split into five distinct categories, according to the paper in The Lancet Diabetes and Endocrinology.
Ms. Postigo and Mr. Thomas will review your personal statement! Submit your personal statement at go.fiu.edu/psreview. Please allow for a three week turnaround on all submissions.